Absolute Return Capital’s Quest Diagnostics DGX Stock Holding History

Absolute Return Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-148,290	Closed	-$9.12M	–	109
2015 Q3	$9.12M	Sell	148,290 -131,466	-47%	-$9.19M	0.58%	51
2015 Q2	$20.3M	Sell	279,756 -124,031	-31%	-$9.16M	0.81%	21
2015 Q1	$31M	Sell	403,787 -114,315	-22%	-$8.19M	0.82%	19
2014 Q4	$34.7M	Sell	518,102 -263,351	-34%	-$16.6M	0.72%	35
2014 Q3	$47.4M	Buy	781,453 +58,123	+8%	+$3.58M	0.67%	31
2014 Q2	$42.5M	Sell	723,330 -211,424	-23%	-$12.4M	0.5%	43
2014 Q1	$54.1M	Sell	934,754 -79,923	-8%	-$4.28M	0.78%	8
2013 Q4	$54.3M	Buy	1,014,677 +384,110	+61%	+$22.8M	0.6%	34
2013 Q3	$39M	Buy	630,567 +93,230	+17%	+$5.58M	0.54%	44
2013 Q2	$32.6M	Buy	+537,337	New	+$32M	0.42%	63

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Absolute Return Capital's DGX Position: Q4 2015 in Review

Absolute Return Capital sold out of Quest Diagnostics (DGX) in Q4 2015, closing a stake of 148,290 shares — an estimated $9.12M sold.

Absolute Return Capital first reported a position in DGX in Q2 2013 and held it in 10 quarters. The position peaked at $54.3M in Q4 2013. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

Absolute Return Capital reported no remaining Quest Diagnostics position as of Q4 2015 after selling out during the quarter.
Absolute Return Capital sold 148,290 Quest Diagnostics shares in Q4 2015, an estimated $9.12M.
Absolute Return Capital first reported a position in Quest Diagnostics in Q2 2013 and held it in 10 quarters.
Absolute Return Capital's Quest Diagnostics position peaked at $54.3M in Q4 2013.
535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.